Abstract
This study uses SSR Health data on drug list prices and estimated net prices after manufacturer discounts to evaluate trends in prices for newly marketed brand-name prescription drugs in the US from 2008 to 2021.
MeSH terms
-
Drug Costs* / trends
-
Drug Industry* / economics
-
Drug Industry* / trends
-
Drugs, Generic
-
Health Services Accessibility
-
Humans
-
Prescription Drugs* / economics
-
United States
Substances
-
Drugs, Generic
-
Prescription Drugs